![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Journal of Virology, January 2005, p. 299-313, Vol. 79, No. 1
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.1.299-313.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Division of Biotechnology and Molecular Medicine, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana
Received 10 June 2004/ Accepted 25 August 2004
 |
ABSTRACT |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
gBgK was used to isolate the recombinant viruses gBsyn3gK and gBamb1511gK, which lack the gK gene and carry the gBsyn3 or gBamb1511 syncytial mutation, respectively. Both viruses formed small nonsyncytial plaques on noncomplementing Vero cells and large syncytial plaques on gK-complementing cells, indicating that gK expression was necessary for gBsyn3- and gBamb1511-induced cell fusion. Lack of virus-induced cell fusion was not due to defects in virion egress, since recombinant viruses specifying the gBsyn3 or gKsyn20 mutation in the UL19/UL20 double-null genetic background caused extensive cell fusion on UL20-complementing cells. As expected, the gB-null virus failed to produce infectious virus, but enveloped virion particles egressed efficiently out of infected cells. The gK-null and UL20-null viruses exhibited cytoplasmic defects in virion morphogenesis like those of the corresponding HSV-1 (KOS) mutant viruses. Similarly, the gB/gK double-null and gB/UL20 double-null viruses accumulated capsids in the cytoplasm, indicating that gB, gK, and UL20p do not function redundantly in membrane fusion during virion de-envelopment at the outer nuclear lamellae. |
INTRODUCTION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The UL20 and UL53 (gK) genes encode multipass transmembrane proteins of 222 and 338 amino acids, respectively, which are conserved in all alphaherpesviruses (13, 40, 51). UL20p assumes a membrane topology that constitutes a mirror image of gK with both the amino and carboxyl termini of UL20p located intracellularly, while both the amino and carboxyl termini of gK are located extracellularly (17, 21, 41). gK is known to be posttranslationally modified by N-linked carbohydrate addition, while UL20p is not glycosylated (13, 29, 51). UL20p and gK localize to trans-Golgi network membranes after endocytosis from cell surfaces (21). UL20p and gK are essential for cytoplasmic virion morphogenesis, since mutant viruses lacking either gK or UL20p accumulate capsids within the cytoplasm that are unable to acquire envelopes by budding into trans-Golgi network-associated membranes (3, 18, 19, 24, 31, 33, 41). Furthermore, UL20p is essential for virus-induced cell fusion caused by either gB or gK syncytial mutations (19), and it is necessary for gK cell surface expression (17, 19, 21), strongly suggesting that direct or indirect interactions between gK and UL20 are necessary for intracellular protein trafficking, virus egress, and virus-mediated cell-to-cell fusion (15, 17, 19, 24, 41).
Glycoprotein B (gB) is highly conserved across all subfamilies of herpesviruses. It exists within cells as a homodimeric type I integral membrane protein that is N-glycosylated at multiple sites (10, 11, 27, 37, 53, 59). A variety of evidence indicates that gB plays important roles in membrane fusion phenomena during virus entry and virus-induced cell fusion: herpes simplex virus type 1 (HSV-1) mutants lacking gB are not able to enter cells (6) due to a postattachment defect that can be resolved by polyethylene glycol-mediated fusion of viral envelopes with cellular membranes (7); single-amino-acid substitutions and truncations of the carboxyl terminus of gB cause extensive virus-induced cell fusion (2, 5, 8, 25); and transient coexpression of gB with gD, gH, and gL causes cell-to-cell fusion, which is substantially increased by carboxyl-terminal truncations of gB (20, 26, 34, 48). These results suggest a direct role for gB in membrane fusion and suggest that perturbations of the carboxyl-terminal domains of gB facilitate gB-mediated cell-to-cell fusion.
It has been shown that syncytial mutations in gK failed to cause virus-induced cell fusion in the absence of gB, indicating that gB was essential for gK-associated cell-to-cell fusion (7). In this paper, we used the HSV-1 (F) bacterial artificial chromosome BAC system (62) to generate multiple mutant viruses lacking either gK, UL20, or gB or combinations of gK and gB or UL20 and gB. Comparison of the BAC-generated insertion-deletion mutants in the HSV-1 (F) genetic background revealed subtle but important differences in individual virus phenotypes in comparison to the laboratory-adapted virus strain KOS, most likely due to the limited passage of these viruses in cell culture. In addition, mutant viruses carrying syncytial mutations in gB in the absence of either gK or UL20 were generated. Characterization of these viruses revealed that gK is necessary for gB-mediated virus-induced cell fusion. Concurrent deletion of either gB and gK or gB and UL20p did not prevent perinuclear virion de-envelopment, indicating that gB and gK or gB and UL20p do not function redundantly in mediating fusion between the viral envelopes and the outer nuclear membrane.
|
MATERIALS AND METHODS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Plasmids.
Plasmid pcDNA5/FRT/gK was constructed by inserting the gK gene, PCR amplified from KOS viral DNA, into pcDNA5/FRT/V5-His-TOPO (Invitrogen). Plasmid p20F2 contains a 7,185-bp HSV-1 (KOS) genomic fragment spanning the region comprising UL19, UL20, UL21, and UL22 and was described previously (41). Primers 5'CMVEGFP_20.5_BclI (5'-TTCTTCTTCTTCTGATCATGCTGACGTAAGTAGTTATTAATAGTAATCAATTACGGGG-3') and 3'CMVEGFP_BclI (5'-CTCTTCCTCTCCTGATCAATGAGTTTGGACAAACCACAACTAGA-3') were used to PCR amplify a cytomegalovirus-enhanced green fluorescent protein (EGFP) gene cassette from pTF9200 (22). The resultant PCR product was digested with BclI and ligated into p20F2 that was restricted the BamHI and treated with calf intestinal phosphatase. The resultant plasmid, designated p1920-EGFP, contained a cytomegalovirus-EGFP gene cassette which replaced the HSV-1 region in p20F2 contained within the BamHI sites at genomic positions 39234 and 41549 (GenBank accession number NC_001806), removing the entire UL20 open reading frame (ORF) as well as the first 1,293 bp of the UL19 ORF.
Construction of transformed Flp-In-CV-1 cell lines.
Generation of stable Flp-In-CV-1 expression cell lines was performed essentially as directed by the manufacturer (Invitrogen) and as described previously (41). Confluent Flp-In-CV-1 monolayers in six-well plates were transfected with 0.3 µg of pcDNA5/FRT/gK and 2.7 µg of pOG44 (Invitrogen), which expresses Flp recombinase, with Lipofectamine 2000. After 2 weeks, hygromycin B (125 µg/ml)-resistant colonies were tested for the ability to complement the growth of YEbacgK virus. All colonies tested complemented YEbacgK virus. Isolate FcgK-1, derived from pcDNA5/FRT/gK-transfected cells, was chosen for further use. FcgK-1 cells were used in generating YEbacgK virus stocks.
Construction of a replication-deficient adenovirus expressing gB.
pAd5-Blue is a replication-defective, E1- and E3-deleted adenovirus type 5 (Ad5)-containing plasmid (44). gB was PCR amplified from HSV-1 KOS viral DNA with primers gB5'ClaI (5'-TCCTCCATCGATATGCGCCAGGGCGCCCCCG-3') and gB3'XbaI (5'-CTTCTTTCTAGATCACAGGTCGTCCTCGTCGGC-3') and transferred into the unique ClaI and XbaI sites located in the E1-deleted region of pAd5-Blue, immediately downstream of the cytomegalovirus promoter, to generate pAd5-gB. pAd5-gB was transfected into 293 cells in a T-25 flask with Lipofectamine 2000, according to the manufacturer's directions (Invitrogen); 72 h posttransfection, cell lysates were prepared by multiple freeze-thaw cycles. A small portion of the cell lysate was then used to infect a subsequent flask of 293 cells. After four passages, a high-titer stock of Ad5-gB was obtained, which was deficient for replication on Vero cells. Ad5-gB virus at different multiplicities of infection (MOIs) was tested for its ability to complement YEbacgB on Vero cells, and an MOI of 10 was found to be optimal.
Construction of HSV-1 mutants with deletions of the UL20, gB, and/or gK genes (pYEbac102, pYEbacgB, pYEbacUL20, pYEbacgK, pYEbacgBUL20, and pYEbacgBgK).
Insertion-deletion mutagenesis of pYEbac102 DNA was accomplished in Escherichia coli with the 
gam recE recT (GET) recombination system (45, 46), as described previously for mutagenesis of the KSHV genome (39). Electrocompetent YEbac102 Escherichia coli DH10B cells were transformed with plasmid pGETrec, which contains the genes encoding recE, recT, and bacteriophage gam, grown on plates containing chloramphenicol (12.5 µg/ml) and ampicillin (100 µg/ml). Individual colonies were picked and grown overnight in Luria-Bertani (LB) medium containing chloramphenicol and ampicillin. The next day, the culture was inoculated into 250 ml of LB containing chloramphenicol and ampicillin until an optical density at 600 nm of 0.4 was reached. Addition of L-arabinose to a final concentration of 0.2% (wt/vol) and further incubation for 40 min induced expression of the recE, recT and gam genes from plasmid pGETrec. The cells were then harvested and made electrocompetent.
For the UL20-GFPzeo mutation, a PCR fragment containing a GFP-zeocin resistance (GFP-zeo) gene cassette flanked by 
50 bp of viral sequences on both sides was used for recombination to construct pYEbacUL20, containing the GFP-zeo gene cassette within the targeted UL20 genomic region. For the gB-Kan mutation, a PCR fragment containing a kanamycin resistance gene cassette flanked by 50 bp of viral sequences on both sides was used for recombination to construct pYEbacgB, which contained the kanamycin resistance gene cassette within the targeted UL27 genomic region. For gK-GFPzeo, a PCR fragment containing a GFP-zeo gene cassette flanked by 50 bp of viral sequences on both sides was used for recombination to construct pYEbacgK, containing the GFP-zeo gene cassette within the targeted UL53 genomic region. Briefly, 40 µl of electrocompetent DH10B cells harboring both pYEbac102 and pGETrec were electroporated with 200 ng of each PCR product to delete the target gene (gB, UL20, or gK) with standard electroporation parameters (1.8 kV/cm, 200 
, and 25 µF). Following electroporation, cells were grown in 1 ml of LB for 60 min and subsequently streaked onto LB agar plates containing chloramphenicol (12.5 µg/ml) as well as either kanamycin (50 µg/ml) or zeocin (25 µg/ml). Mutant pYEbac102 DNA containing a deletion in the gB, UL20, or gK gene was isolated from bacterial colonies, and a second round of electroporation was performed to remove plasmid pGETrec. Following electroporation, cells were grown on agar plates containing chloramphenicol as well as either kanamycin or zeocin. Similar procedures were followed, starting with electrocompetent DH10B E. coli cells harboring pYEbacgB, in order to generate pYEbacgBgK and pYEbacgBUL20.
Confirmation of the targeted mutations in pYEbac102 DNA.
HSV-1 BAC DNAs (pYEbac102, pYEbacgB, pYEbacUL20, pYEbacgK, pYEbacgBUL20, and pYEbacgBgK) were purified from 500 ml of BAC cultures with the Qiagen large-construct kit (Qiagen; Valencia, Calif.). BAC DNA was digested with KpnI, run on a 0.7% agarose gel, and transferred to charged nylon membranes (Bio-Rad; Richmond, Calif.). Southern blot hybridization was performed with either a 1.1-kb kanamycin or 800-bp GFP-zeocin PCR product labeled with biotin (New England Biolabs; Boston, Mass.). Chemiluminescence detection of the DNA was performed with the North2South chemiluminescent hybridization and detection kit as described by the manufacturer (Pierce Inc.; Rockford, Ill.). All mutations were sequenced to verify the presence of the desired mutations in the BACs. To verify that no spurious mutations were introduced into the viral genome of the individual BAC mutants during mutagenesis or during the transfection procedure, each null mutation was rescued by homologous recombination with DNA fragments spanning each gene. Each rescue virus was verified to have the phenotypic and replication characteristics of the wild-type BAC YEbac102.
Transfection of HSV-1 BAC DNAs. Transient transfection of cells with BAC DNAs was performed with Lipofectamine 2000 (Invitrogen). Complementing cell lines were grown to 95% confluency in six-well plates. Cells were transfected with BAC DNA mixed with Lipofectamine 2000 in Opti-MEM medium as recommended by the manufacturer (Invitrogen). After 6 h of incubation at 37°C, the medium was removed from the transfected cells, cells were washed with phosphate-buffered saline, and subsequent fresh Dulbecco's modified Eagle's medium with 10% fetal calf serum was added. At 72 h posttransfection, virus stocks were collected.
Plaque morphology of YEbac102 mutants.
For plaque morphology, Vero, Fd20-1, FcgK-1, and D6 cells were infected at MOIs of 0.01 and 0.001 with the YEbac102, YEbacgB, YEbacUL20, YEbacgK, YEbacgBgK, and YEbacgBUL20 viruses and visualized by immunohistochemistry at 48 h postinfection with horseradish peroxidase-conjugated anti-HSV antibodies (Dako) and Novared (VectorLabs) substrate development. For complementation of YEbacgBgK and YEbacgBUL20 viruses, Fd20-1 and FcgK-1 were infected with Ad5-gB at an MOI of 10, 1 h prior to HSV-1 infection. Due to the constitutive expression of gB in all cells, plaques were visualized by immunohistochemistry at 48 h postinfection with an anti-gD monoclonal antibody (RG-1103; Rumbaugh-Goodwin Institute; Plantation, Fla.) with the Vectastain Elite ABC kit and Novared substrate development kit (VectorLabs; Burlingame, Calif.) according to the manufacturer's directions and as described previously (17, 19).
One-step growth kinetics of YEbac102 mutants. Analysis of one-step growth kinetics was as described previously (17, 23). Briefly, each virus at an MOI of 5 was adsorbed to approximately 6 x 105 Vero cells at 4°C for 1 h. Thereafter, warm medium was added, and virus was allowed to penetrate for 2 h at 37°C. Any remaining extracellular virus was inactivated by low-pH treatment (0.1 M glycine, pH 3.0). Cells and supernatants were harvested immediately thereafter (0 h) or after 4, 9, 16, 20, or 24 h of incubation at 37°C. Virus titers were determined by endpoint titration of virus stocks on a complementing cell line.
Generation of recombinant UL20-null and gK-null viruses specifying mutant gB.
In order to generate recombinant viruses specifying mutations in gB, PCR amplification of the UL27 region from purified viral DNA of YEbac102 (wild-type gB), tsb5 (gBsyn3), or amb1511 (gBamb1511) was performed. Each PCR product was used for homologous recombination with both the YEbacgBUL20 and YEbacgBgK viruses. Virus plaques that formed on Fd20-1 (UL20 complementing) or FcgK-1 (gK complementing) cells were picked and sequentially plaque purified at least five times. Replacement of the gB-null resident kanamycin resistance cassette and concomitant insertion of the specific mutant gB gene were confirmed by DNA sequencing.
Generation of UL19 and UL20 double-null viruses.
Viruses that contained a cytomegalovirus immediate-early promoter-driven EGFP gene cassette in place of a UL19/UL20 gene deletion were generated by homologous recombination with plasmid p1920-EGFP and the parental virus gKDIV5, gKsyn20DIV5, or tsB5 (gBsyn3). G5 cells were transfected with p1920-EGFP and at 6 h posttransfection were infected at an MOI of 0.1 with either gKDIV5, gKsyn20DIV5, or tsB5 (gBsyn3) to generate UL19 and UL20 double-null viruses that were designated 1920, 1920-syn20, and 1920-syn3, respectively. Viruses were subsequently plaque isolated on G5 cells by fluorescence microscopy and sequentially plaque purified at least five times. Insertion of the cytomegalovirus-EGFP gene cassette and the concomitant deletion of the UL19 and UL20 genes were confirmed by diagnostic PCR and DNA sequencing.
Electron microscopy. Cell monolayers were infected with the indicated virus at an MOI of 3. All cells were prepared for transmission electron microscopy (TEM) examination 24 h postinfection. Infected cells were fixed in a mixture of 2% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.3. Following treatment with 1% OsO4 and dehydration in an ethanol series, the samples were embedded in Epon-Araldyte resin and polymerized at 70°C. Thin sections were made on an MTXL ultratome (RMC Products), stained with 5% uranyl acetate and citrate/nitrate/acetate lead, and observed with a Zeiss 10 transmission electron microscope as described previously (19, 41).
|
RESULTS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
gB, pYEbacUL20, pYEbacgK, pYEbacgBUL20, and pYEbacgBgK.
The complete HSV-1 (F) genome was recently cloned into a bacterial artificial chromosome (pYEbac102), enabling genetic manipulation of the HSV-1 genome in E. coli (62). The BAC-based GET homologous recombination system was used to construct deletions within the gB, UL20, and gK genes in E. coli. Deletion of each gene was accomplished by targeting the gB, UL20, or gK open reading frame (ORF) with specific primers as detailed in the Materials and Methods section. For construction of the UL20-GFPzeo mutation, primers A and B were used for homologous recombination and positioned to remove a 353-bp region of the UL20 gene upon insertion of a GFP-zeocin resistance gene cassette (Table 1; Fig. 1B and C), extending from the UL20 ATG to an HpaI site inside the UL20 ORF.
|
|
gB-Kan mutation). Specifically, primers C and D were designed to remove a 970-bp fragment starting with gB ORF nucleotide 1655 upon homologous recombination with pYEbac102 (Table 1; Fig. 1B and C). This gB deletion does not disrupt the UL27.5 ORF overlapping the 5' end of gB (9) and is similar to that of the KT gB-null virus (6), with the exception that the gB-Kan mutation was constructed to include a stop codon at the 5' end of the kanamycin resistance cassette ensuring that no aberrant proteins could be made via a translational readthrough of the kanamycin resistance gene cassette.
For construction of the gK-GFPzeo mutation, primers E and F were positioned to delete almost the entire gK gene (941 bp) without affecting the proximal UL52 gene, which partially overlaps the gK ORF (Table 1; Fig. 1B and C). Each pYEbac102 mutant construct contains one or more of the insertion-deletion mutations mentioned above: pYEbacgB contains the gB-Kan mutation; pYEbacUL20 contains the UL20-GFPzeo mutation; pYEbacgK contains the gK-GFPzeo mutation; pYEbacgBUL20 contains both the gB-Kan and the UL20-GFPzeo mutations; and pYEbacgBgK contains both the gB-Kan and the gK-GFPzeo mutations.
The YEbac102 viral constructs were tested for the presence of the engineered insertion-deletion mutation via diagnostic PCR. Primers a and b (Table 1; Fig. 1A), located outside of the UL20 gene, amplified the predicted 909-bp diagnostic UL20 DNA fragments from BACs that contain wild-type UL20, while a predicted 2,469-bp product was produced from BACs that contain the UL20-GFPzeo mutation (Fig. 2A, panel i). Primers c and d (Table 1; Fig. 1A) located within gB but outside the deleted region amplified the predicted 2,127-bp diagnostic gB DNA fragment from BACs that contain wild-type gB, while a predicted 2,261-bp product was produced from BACs that contain the gB-Kan mutation (Fig. 2A, panel iii). Primers e and f (Table 1; Fig. 1A) located outside of the gK deletion region amplified a 1,265-bp diagnostic gK DNA fragment from BACs that contain wild-type UL20, while a predicted 2,238-bp product was produced from BACs that contain the gK-GFPzeo mutation (Fig. 2A, panel ii).
|
gB, pYEbacUL20, pYEbacgK, pYEbacgBUL20 and pYEbacgBgK DNA with KpnI produced a similar genomic DNA restriction pattern with a few exceptions caused by the specified alterations of gB, UL20, and gK containing KpnI DNA fragments. First, the 4,701-bp band containing the UL27 (gB) ORF increased in size by 134 bp to 4,835 bp for pYEbacgB, pYEbacgBUL20, and pYEbacgBgK as a result of the gB-Kan mutation. This 4,835-bp KpnI DNA fragment (demarcated by a black arrow) was visible in the lanes labeled with the above-mentioned constructs appearing between the predicted 4,680-bp and 4959-bp KpnI DNA fragments (Fig. 2B). In addition, Southern blot analysis revealed that a kanamycin resistance gene cassette probe hybridized to a single 4,835-bp KpnI DNA fragment contained only in pYEbacgB, pYEbacgBUL20, and pYEbacgBgK restriction digests (indicated by a black arrow) (Fig. 2C), indicating that the gB-Kan mutation had been successfully transferred into a single genomic site.
Second, the wild-type 9,432-bp KpnI DNA fragment containing the UL20 ORF increased in size by 1,560 bp to 10,992 bp for pYEbacUL20 and pYEbacgBUL20. It is apparent that the 9,432-bp band is missing in pYEbacUL20 and pYEbacgBUL20, as indicated by a gray arrow (Fig. 2B). However, the 10,992-bp KpnI DNA fragment is not easily identifiable due to the presence of KpnI genomic fragments with predicted sizes of 10,837 and 11,024 bp. The 10,992-bp DNA fragment contains the UL20-GFPzeo mutation, which was confirmed by probing the corresponding blot with a GFP-zeocin probe (Fig. 2D, gray arrow). The GFP-zeocin probe hybridized to unique DNA fragments of the predicted sizes for both pYEbacUL20 and pYEbacgBUL20. Finally, the gK-GFPzeo mutation is predicted to increase the size of the wild-type 7,983-bp DNA fragment containing the UL53 (gK) ORF by 973 to 8,956 bp. These DNA fragments were not readily discernible in the ethidium bromide-stained restriction profile (Fig. 2A). However, the GFP-zeocin probe hybridized to the 8,956-bp DNA fragment (white arrow) in pYEbacgK and pYEbacgBgK, confirming the creation of the gK-GFPzeo mutation (Fig. 2C). Again, the presence of a single DNA fragment detected by the GFP-zeocin probe indicates the absence of any spurious insertions.
Generation of infectious virus from pYEbac102-based constructs.
To generate virus stocks from the mutant pYEbac102 constructs, transient transfection of individual BAC DNAs into specific cell lines transformed with either the gB, UL20, or gK gene and capable of complementing the resultant viruses was performed. Specifically, pYEbac102 was transfected into Vero cells, pYEbacgB into gB-complementing D6 cells (6), pYEbacUL20 into UL20-complementing Fd20-1 cells (42), and pYEbacgK into FcgK-1 cells. The FcgK-1 cell line constitutively expresses the gK gene under the cytomegalovirus immediate-early promoter and was constructed to efficiently complement the gK-GFPzeo mutation and minimize the chance for generation of wild-type viruses via recombination with the endogenous gK gene (see Materials and Methods). For all transfection experiments, virus plaques became visible 72 h posttransfection, and virus stocks exhibiting maximum cytopathic effects were collected at appropriate points.
For complementation of the double-null viruses produced by transfection of pYEbacgBUL20 and pYEbacgBgK, the replication-deficient adenovirus Ad5-gB was constructed, which constitutively expresses gB under the cytomegalovirus immediate-early promoter (see Materials and Methods). A series of experiments were performed to assess the optimum MOI of this virus that could maximize complementation of gB-null viruses. These experiments showed that Ad5-gB at an MOI of 10 efficiently complemented gB-deficient viruses (not shown). To complement double-null viruses having the gB gene deletion, UL20- or gK-complementing cell lines were infected with Ad5-gB 1 h prior to transfection with pYEbacgBUL20 or pYEbacgBgK. The same strategy was used to amplify virus stocks of the double-null viruses.
Plaque morphology and growth kinetics of HSV-1 YEbac102 mutants. HSV-1 viruses containing deletions in UL20, gB, and gK have been described previously (3, 6, 19, 30, 33). These viruses were produced by homologous recombination of plasmid constructs with viral DNA in cell culture experiments. Typically, isolation of these viruses required multiple plaque purifications to ensure that the mutant virus stocks did not contain contaminating wild-type virus. In contrast, the YEbac102 UL20, gB, and gK null viruses were constructed in E. coli with the GET recombination system (45, 46). In this case, production of mutant viruses did not require any plaque purification, since the progeny viruses did not contain any contaminating wild-type genomes.
To assess the effect of the deletion of the various genes on cell-to-cell spread, the plaque morphologies of the YEbac102, YEbacgB, YEbacUL20, and YEbacgK viruses were examined in Vero, Fd20-1, D6, and FcgK-1 cells at 48 h postinfection (Fig. 3). The wild type YEbac102 produced large plaques of a similar size on all infected cells (Fig. 3A). Infection of noncomplementing cells with either YEbacUL20 or YEbacgK resulted in small plaques containing on average three to five cells (Fig. 3B1, B3, B4, D1, D3, and D3, respectively), while complementation of the UL20 and gK gene deletions resulted in large plaques comparable in size to the YEbac102 plaques (Fig. 3B2 and D4, respectively). Similarly, infection of noncomplementing cells with the YEbacgB virus produced only single infected cells (Fig. 3C1, C2, and C4), indicating that the virus was unable to spread beyond the primary infected cell, while infection of complementing D6 cells resulted in large plaques (Fig. 3C3). The YEbacgBUL20 and YEbacgBgK double-null viruses formed large plaques when plated onto Ad5-gB-infected Fd20-1 or FcgK-1 cells, respectively (Fig. 4A5 and B6), single infected cells on Vero cells, or cells able to complement for only gK or UL20 (Fig. 4A1, A2, A4, B1, B2, and B4), or very small plaques in cells able to complement gB (Fig. 4A3, A6, B3, and B5).
|
|
To examine the effect of the various mutations on virus replication, Vero cells were infected at an MOI of 5 with either the wild-type or a mutant virus. Virus stocks were prepared at 0, 4, 9, 16, 20, or 24 h postinfection and titrated in triplicate onto complementing cells (Fig. 5). The kinetics of both YEbacUL20 and YEbacgK viral replication was substantially slower than that of the YEbac102 virus. Maximum titers for the YEbacUL20 and YEbacgK mutants viruses were 105 PFU/ml in comparison to 108 PFU/ml for the YEbac102 virus at 24 h postinfection (Fig. 5). In contrast, the YEbacgB, YEbacgBUL20, and YEbacgBgK viruses failed to produce infectious virus in Vero cells (Fig. 5).
|
gBUL20 and YEbacgBgK double-null mutant viruses.
Previous reports indicated that gB was not essential for virion egress (6, 7), while both gK and UL20p were found to be essential for cytoplasmic virion morphogenesis and egress (19, 33). To ascertain whether gB functioned redundantly with either gK or UL20p in virion de-envelopment from perinuclear spaces, the ultrastructural phenotypes of each YEbac102-based mutant virus carrying UL20, gB, or gK deletions relative to the wild-type YEbac102 virus were determined by transmission electron microscopy at 24 h postinfection.
As expected, the YEbac102 and YEbacgB viruses exhibited no apparent defects in virion egress, exemplified by the presence of fully enveloped virions extracellularly (Fig. 6A and B) as well as the presence of fully enveloped virions intracellularly (not shown). Unlike the wild-type virus, ultrastructural visualization of YEbacUL20- and YEbacgK-infected Vero cells revealed a cytoplasmic defect in virion egress, characterized by the presence of unenveloped capsids in the cytoplasm as well as aberrantly enveloped virions (Fig. 6C and D). These results are consistent with previous findings (19, 33). In general, ultrastructural examination of Vero cells infected with the YEbacgBgK (Fig. 7A) and YEbacgBUL20 (Fig. 7B) double-null viruses revealed virion morphogenetic defects similar to those of the gK- and UL20-null viruses, exhibiting large numbers of unenveloped capsids in the cytoplasm. In addition, the observed ultrastructural phenotypes revealed specific defects in cytoplasmic envelopment: (i) multiple capsids appeared proximal to membranes apparently unable to complete the budding process into cytoplasmic vesicles (Fig. 7A4 and B3) and (ii) cytoplasmic vesicular membranes appeared to contain electron-dense material consistent with the accumulation of tegument proteins in the presence or absence of proximal capsids (Fig. 7A5 and B4).
|
|
gBgK virus with either wild-type gB, gBsyn3, or gBamb1511 (see Materials and Methods). The same strategy was used to isolate recombinant viruses carrying the gBsyn3 or gBamb1511 mutation in the absence of the UL20 gene by rescuing the gB deletion in the YEbacgBUL20 virus. To assess the effect of each gB mutation on virus-induced cell fusion, Vero cells as well as either gK- or UL20-complementing cells were infected with each mutant virus at an MOI of 0.001. Virus plaques were visualized at 48 h postinfection by immunohistochemistry as described previously (19, 41). Viruses specifying the wild-type, syn3, or amb1511 gB in the gK-null background formed small, nonsyncytial plaques on Vero cells (Fig. 8A, C, and E). As expected, the virus containing the wild-type gB formed large, nonsyncytial plaques on FcgK-1 cells (Fig. 8B), while gK-null viruses specifying either the gBsyn3 or gBamb1511 mutation formed large, syncytial plaques on FcgK-1 cells (Fig. 8D and F). Similarly, UL20-null viruses specifying wild-type, syn3, or amb1511 gB formed small, nonsyncytial plaques on Vero cells (Fig. 8G, I, and K). The UL20-null virus containing wild-type gB formed large, nonsyncytial plaques on Fd20-1 cells (Fig. 8H), and the UL20-null viruses specifying either the gBsyn3 or gBamb1511 mutation formed large, syncytial plaques on Fd20-1 cells (Fig. 8J and L).
|
1920, 1920-syn20, and 1920-syn3 viruses at an MOI of 0.005. As expected, these infections did not cause virus-induced cell fusion in noncomplementing CV-1 cells (Fig. 9A, C, and E). However, the 1920-syn20 and 1920-syn3 viruses formed syncytial plaques containing a range of 3 to 100 nuclei per syncytium in Fd20-1 cells, which complement only UL20 (Fig. 9D and F), while the 1920 virus failed to cause virus-induced cell fusion (Fig. 9B).
|
|
DISCUSSION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Taking advantage of the HSV-1 pYEbac102 system, we generated recombinant viruses lacking either the gK, gB, or UL20 gene as well as viruses having deletions in both gK and gB or gB and UL20. As expected, the gB/gK and gB/UL20 double-null viruses failed to produce infectious virus or spread beyond the primary infected Vero cells. Generally, the gK-, gB-, and UL20-null viruses exhibited defects in virus replication and plaque morphologies similar to those of corresponding viruses constructed in the KOS genetic background. However, it was noted that the HSV-1 (F) gK- and UL20-null viruses exhibited up to 10-fold greater defects in virus replication, while virus plaques were typically smaller than those produced by the KOS mutant viruses. These results may be attributed to genetic differences between the F and KOS virus strains, although no apparent differences were noted between the wild-type viruses with regard to their replication kinetics and plaque morphology. Alternatively, it is possible that the requirement for extensive passage of mutant viruses in the KOS background during plaque purification may have resulted in improved adaptation of these viruses for growth in Vero cells. In this regard, generation of mutant viruses via the pYEbac102 system provides a unique advantage in assessment of the structure and function of individual viral proteins without the potential complications arising from extensive cell culture passage of virus stocks.
gB, UL20p, and gK are not required for virion de-envelopment. HSV-1 is thought to acquire an initial envelope when capsids formed in the nucleus of cells bud into the perinuclear space. Subsequently, a putative fusion event between viral envelopes and the outer nuclear membranes results in capsid release into the cytoplasm. Final envelopment is thought to occur by budding into cytoplasmic vesicles derived from the trans-Golgi network or endosomes that facilitate egress of enveloped virions to extracellular spaces (Fig. 10). Currently, it is not known whether viral glycoproteins involved in virus entry or virus-induced cell fusion also functions in this de-envelopment step. The results obtained in this study clearly show that gK, UL20, and gB are not essential for virion de-envelopment.
|
Virions found in perinuclear spaces are known to contain the UL34 and UL31 tegument proteins, which are absent from extracellular enveloped virions (52). Thus, it is possible that the de-envelopment process involves tegument-membrane protein interactions different from those occurring during virus entry. In this regard, virion de-envelopment from perinuclear spaces seems to bear little similarity to either virus entry or virus-induced cell fusion, suggesting that this membrane fusion event may be regulated by a fundamentally different mechanism.
Role of gK in gB-mediated cell-to-cell fusion. Previous reports showed that gK syncytial mutations could not cause virus-induced cell fusion in the absence of gB, indicating that gB served functions essential for cell-to-cell fusion (7). Both the gBsyn3 and gBamb1511 mutations cause extensive virus-induced cell fusion (2, 5). However, unlike the gBsyn3 single-amino-acid mutation, which does not enhance gB-mediated fusion in the transient coexpression system, the gBamb1511 truncation causes greatly enhanced fusion in the transient expression system (20). These findings suggest that the gBamb1511 truncation may disengage gB from other viral or cellular functions responsible for downregulation of the fusogenic potential of gB. However, recombinant viruses containing the gB syncytial mutation gBsyn3 or gBamb1511 but lacking the gK or the UL20 gene failed to cause virus-induced cell fusion, indicating that expression of both gK and UL20p is required for gB-mediated membrane fusion.
In addition, deletion of the carboxyl-terminal 28 amino acids of gB specified by the amb1511 mutation does not abolish the requirement for expression of both gK and UL20p in gB-mediated virus-induced cell fusion, suggesting that gB amino acid sequences other than the carboxyl-terminal 28 amino acids are required for gK or UL20p regulatory interactions with gB. Recently, gK expression was reported to inhibit membrane fusion caused by coexpression of gB, gD, gH, and gL (1). These findings seem to contradict results obtained herein with the recombinant viruses lacking gK. However, a similar result was reported for gM, which inhibited membrane fusion in the transient coexpression system (34, 36) but was required for virus-induced cell fusion caused by syncytial mutations in gB (12). These results suggest that gM and gK may regulate virus-induced cell fusion both positively and negatively depending on the presence of different sets of viral proteins.
Virion egress is not required in virus-induced cell fusion. Virus-induced cell fusion starts at approximately 5 h postinfection at 37°C, at which time infectious virions are produced and egress out of infected cells. Therefore, it is possible that egressing virions may contribute directly or indirectly to the virus-induced membrane fusion phenomena mediated by cell surface-expressed gB and gK carrying syncytial mutations. It has been shown that cell surface expression of gB is not affected in a gK-null or UL20-null virus (19, 33). Therefore, the requirement for the presence of UL20p and gK for gB-mediated virus-induced cell fusion may be due to defects in virion egress. Earlier reports indicated that production of virion particles may not be necessary for virus-induced cell fusion, inasmuch as syncytial mutants caused fusion in the presence of the replication inhibitor phosphonoacetic acid (35). These early findings were confirmed herein by the phenotype of the UL19/UL20 double-null viruses containing either the gBsyn3 or gBamb1511 mutation. These viruses are unable to form capsids because of the deletion in the UL19 gene, coding for the major capsid protein VP5. Both viruses caused virus-induced cell fusion in the UL20-complementing cell line, indicating that virion formation and egress are not necessary for virus-induced cell fusion.
The rapid generation of recombinant viruses with the YEbac102 system greatly facilitates the characterization of the function of individual viral proteins while helping to discern potentially complex interactions among multiple proteins through the introduction of multiple mutations into an identical genetic background. In this report, we have demonstrated the utility of this system in investigating the role of gB, gK, and UL20p in virus-induced cell fusion and morphogenesis. The existence of an intimate relationship between gK/UL20p and gB in virus-induced cell fusion suggests that both gK and UL20p act to regulate the fusogenic properties of gB. Future studies will investigate direct physical interactions among gB, gK, and UL20p and their role in the regulation of membrane fusion phenomena in the HSV-1 life cycle.
|
ACKNOWLEDGMENTS |
|---|
We thank Olga Borkshsenious for expert technical assistance with electron microscopy. We are indebted to Dr. Y. Kawaguchi for providing pYEbac102.
|
FOOTNOTES |
|---|
|
REFERENCES |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
),YEbac
),YEbac
),YEbac
), and YEbac
) on Vero cells. One-step kinetics of infectious virus production were calculated after infection at an MOI of 5 followed by incubation at 37°C.
